Drug intelligence / Profile preview

ginseng + lily extract

Development stage
Unknown
Lead developer
Amway
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

CC001 is a botanical combination formula developed by the Amway (China) R&D Center, consisting of extracts from ginseng (*Panax ginseng*) and lily (*Lilium brownii*). The formulation is primarily investigated for its potential protective effects against respiratory damage and cardiovascular stress, particularly in the context of environmental pollutants such as PM2.5. Clinical evaluation has focused on the formula's ability to modulate inflammatory markers and improve antioxidant status in healthy adults exposed to air pollution. The product leverages the adaptogenic and anti-inflammatory properties of ginsenosides from ginseng alongside the traditional respiratory-supportive properties of lily polysaccharides.

Brand names
Nutrilite
Other names
ginseng and lily extractCC001 botanical extractCC-001 botanical extractCC 001 botanical extract

Beyond the preview

Go deeper on ginseng + lily extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginseng + lily extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call